Adventure travel and type 1 diabetes: the complicating effects of high altitude guidelines on exercise and diabetes-Aerobic and. Resistance Training …
References
1 Wild S et al 2004 Global prevalence of diabetes: estimates for the
year 2000 and projections for 2030 Diabetes Care 27: 1047-1053
2 King H et al 1998 Global burden of diabetes, 1995-2025: prevalence,
numerical estimates, and projections Diabetes Care 21: 1414-1431
3 Klein R et al 1996 The incidence of hypertension in insulin-
dependent diabetes Arch Intern Med 156: 622-627
4 Wannamethee SG et al 2005 Metabolic syndrome vs Framingham Risk
Score for prediction of coronary heart disease, stroke, and type 2
diabetes mellitus Arch Intern Med 165: 2644-2650
5 Adler AI et al 2000 Association of systolic blood pressure with
macrovascular and microvascular complications of type 2 diabetes UKPDS
36: prospective observational study BMJ 321: 412-419
6 Najarian RM et al 2006 Metabolic syndrome compared with type 2
diabetes mellitus as a risk factor for stroke: the Framingham Offspring
Study Arch Intern Med 166: 106-111
7 Chobanian AV et al 2003 Seventh report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure
Hypertension 42: 1206-1252
8 No authors listed 1994 National High Blood Pressure Education
Program Working Group report on hypertension in diabetes Hypertension
23: 145-158
9 Makrilakis K and Bakris G 1998 Diabetic hypertensive patients:
improving their prognosis J Cardiovasc Pharmacol 31 Suppl 2: S34-S40
10 Arauz-Pacheco C et al 2003 Treatment of hypertension in adults with
diabetes Diabetes Care 26 Suppl 1: S80-S82
11 Cooper ME and Johnston CI 2000 Optimizing treatment of hypertension
in patients with diabetes JAMA 283: 3177-31179
12 No authors listed 1998 Tight blood pressure control and risk of
macrovascular and microvascular complications in type 2 diabetes: UKPDS
38 UK Prospective Diabetes Study Group BMJ 317: 703-713
13 No authors listed 1998 Efficacy of atenolol and captopril in
reducing risk of macrovascular and microvascular complications in type 2
diabetes: UKPDS 39 UK Prospective Diabetes Study Group BMJ 317: 713-720
14 No authors listed 2000 Effects ramipril on cardiovascular and
microvascular outcomes in people with diabetes mellitus; results of the
HOPE study and
MICRO-HOPE substudy Heart Outcomes Prevention Evaluation
HOPE Investigators Lancet 355: 253-259
